Literature DB >> 23537672

Pediatric sepsis: challenges and adjunctive therapies.

William Hanna1, Hector R Wong.   

Abstract

Sepsis remains an important challenge in pediatric critical care medicine. This review provides an appraisal of adjunctive therapies for sepsis and highlights opportunities for meeting selected challenges in the field. Future clinical studies should address long-term and functional outcomes as well as acute outcomes. Potential adjunctive therapies such as corticosteroids, hemofiltration, hemoadsorption, and plasmapheresis may have important roles, but still require formal and more rigorous testing by way of clinical trials. Finally, the design of future clinical trials should consider novel approaches for stratifying outcome risks as a means of improving the risk-to-benefit ratio of experimental therapies. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537672      PMCID: PMC3612267          DOI: 10.1016/j.ccc.2012.11.003

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  97 in total

1.  Adrenal status in children with septic shock using low-dose stimulation test.

Authors:  Manjunatha Sarthi; Rakesh Lodha; Subbiah Vivekanandhan; Narendra K Arora
Journal:  Pediatr Crit Care Med       Date:  2007-01       Impact factor: 3.624

Review 2.  Decision tree and ensemble learning algorithms with their applications in bioinformatics.

Authors:  Dongsheng Che; Qi Liu; Khaled Rasheed; Xiuping Tao
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 3.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

4.  Extracorporeal removal of endotoxin: the polymyxin B-immobilized fiber cartridge.

Authors:  Tohru Tani; Hisataka Shoji; Gualtiero Guadagni; Angelo Perego
Journal:  Contrib Nephrol       Date:  2010-06-01       Impact factor: 1.580

5.  Neuroendocrine dysfunction in pediatric critical illness.

Authors:  Kiran Hebbar; Mark R Rigby; Eric I Felner; Kirk A Easley; James D Fortenberry
Journal:  Pediatr Crit Care Med       Date:  2009-01       Impact factor: 3.624

6.  Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

Authors:  Dinna N Cruz; Massimo Antonelli; Roberto Fumagalli; Francesca Foltran; Nicola Brienza; Abele Donati; Vincenzo Malcangi; Flavia Petrini; Giada Volta; Franco M Bobbio Pallavicini; Federica Rottoli; Francesco Giunta; Claudio Ronco
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

7.  ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation.

Authors:  Cláudio F de Oliveira; Débora S F de Oliveira; Adriana F C Gottschald; Juliana D G Moura; Graziela A Costa; Andréa C Ventura; José Carlos Fernandes; Flávio A C Vaz; Joseph A Carcillo; Emanuel P Rivers; Eduardo J Troster
Journal:  Intensive Care Med       Date:  2008-03-28       Impact factor: 17.440

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

9.  The pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Shelia Salisbury; Qiang Xiao; Natalie Z Cvijanovich; Mark Hall; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Thomas P Shanley; Michael T Bigham; Anita Sen; Jeffrey Nowak; Michael Quasney; Jared W Henricksen; Arun Chopra; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell
Journal:  Crit Care       Date:  2012-10-01       Impact factor: 9.097

10.  Corticosteroids for severe sepsis: an evidence-based guide for physicians.

Authors:  Djillali Annane
Journal:  Ann Intensive Care       Date:  2011-04-13       Impact factor: 6.925

View more
  17 in total

1.  Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Scott L Weiss; Thomas P Shanley; Michael T Bigham; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Jerry J Zimmerman
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

2.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Authors:  Matthew N Alder; Amy M Opoka; Patrick Lahni; David A Hildeman; Hector R Wong
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

Review 3.  The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.

Authors:  Matthew N Alder; Christopher J Lindsell; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2014-04-22       Impact factor: 5.091

4.  Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults.

Authors:  Hector R Wong; Kathleen D Liu; Kirsten N Kangelaris; Patrick Lahni; Carolyn S Calfee
Journal:  J Crit Care       Date:  2014-04-18       Impact factor: 3.425

5.  Glucocorticoid Receptor Polymorphisms and Outcomes in Pediatric Septic Shock.

Authors:  Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Jocelyn R Grunwell; Amy Opoka; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2017-04       Impact factor: 3.624

6.  Thrombocytopenia and Bloodstream Infection: Incidence and Implication on Length of Stay in the Pediatric Intensive Care Unit.

Authors:  Reut Kassif Lerner; Dana Levinkopf; Inna Zaslavsky Paltiel; Tal Sadeh; Marina Rubinstein; Itai M Pessach; Nathan Keller; Liat Lerner-Geva; Gideon Paret
Journal:  J Pediatr Intensive Care       Date:  2021-01-20

7.  Outcomes of pediatric patients with abdominal sepsis requiring surgery and extracorporeal membrane oxygenation using the Extracorporeal Life Support Organization database.

Authors:  Michael R Phillips; Amal L Khoury; Briana J K Stephenson; Lloyd J Edwards; Anthony G Charles; Sean E McLean
Journal:  Am Surg       Date:  2015-03       Impact factor: 0.688

8.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

9.  Identifying critically ill patients who may benefit from adjunctive corticosteroids: not as easy as we thought.

Authors:  Sarah J Atkinson; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2014-10       Impact factor: 3.624

10.  Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Kelli Howard; Kelli Harmon; Patrick Lahni; Erin Frank; Kimberly W Hart; Trung C Nguyen; Christopher J Lindsell
Journal:  Crit Care Med       Date:  2016-11       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.